Ziconotide

齐考诺肽

Report date: 2022/01/14 13:23:58
NMEFirst In Class

Base Information

Drug NameZiconotide
Drug Alias Name含辛抗宁ZiconotidaZiconotidum齐可诺肽Prialt +[9] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionVoltage-gated N-type calcium channel alpha-1B subunit blockers
TargetsVoltage-gated N-type calcium channel alpha-1B subunit
Therapy Area/IndicationsPain, IntractablePainNeuralgia +[5] 
Global Approved IndicationsPain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2004/12/28
Country/TerritoryUnited StatesItalyEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesElan CorpPerrigo Llc
China Registration ClassN/A

Develop Information

Active CompaniesEsteve Pharmaceuticals LLCNational Cancer Institute NaplesTersera Therapeutics Llc
Inactive CompaniesElan PharmaceuticalsNeurex
Active IndicationsPain, IntractablePainNeuralgia +[4] 
Inactive IndicationsHIV Infections

Other Information

ATC CodeN02BG08
Related LinksWikipediaDrugBankKEGG